Please use this identifier to cite or link to this item:
|Title:||Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus||Authors:||Drosten, C.
|Issue Date:||May-2004||Citation:||Drosten, C., Chiu, L.-L., Panning, M., Leong, H.N., Preiser, W., Tam, J.S., Günther, S., Kramme, S., Emmerich, P., Ng, W.L., Schmitz, H., Koay, E.S.C. (2004-05). Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus. Journal of Clinical Microbiology 42 (5) : 2043-2047. ScholarBank@NUS Repository. https://doi.org/10.1128/JCM.42.5.2043-2047.2004||Abstract:||First-generation reverse transcription-PCR (RT-PCR) assays for severe acute respiratory syndrome-associated coronavirus (SARS-CoV) gave false-negative results in a considerable fraction of patients. In the present study, we evaluated two second-generation, replicase (R) gene-based, real-time RT-PCR test kits-the RealArt HPA coronavirus LC kit (Artus, Hamburg, Germany) and the LightCycler SARS-CoV quantification kit (Roche, Penzberg, Germany)-and a real-time RT-PCR assay for the nucleocapsid (N) gene. Detecting the N-gene RNA might be advantageous due to its high abundance in cells. The kits achieved sensitivities of 70.8% (Artus) and 67.1% (Roche) in 66 specimens from patients with confirmed SARS (samples primarily from the upper and lower respiratory tract and stool). The sensitivity of the N-gene assay was 74.2%. The differences in all of the sensitivities were not statistically significant (P = 0.680 [analysis of variance]). Culture cells initially contained five times more N- than R-gene RNA, but the respective levels converged during 4 days of virus replication. In clinical samples the median concentrations of R- and N-gene RNA, respectively, were 1.2 × 106 and 2.8 × 106 copies/ml (sputum and endotracheal aspirates), 43 × 10 4 and 5.5 × 104 copies/ml (stool), and 5.5 × 102 and 5.2 × 102 copies/sample (throat swabs and saliva). Differences between the samples types were significant but not between the types of target RNA. All (n = 12) samples from the lower respiratory tract tested positive in all tests. In conclusion, the novel assays are more sensitive than the first-generation tests, but they still do not allow a comprehensive ruling out of SARS. Methods for the routine sampling of sputum without infection risk are needed to improve SARS RT-PCR.||Source Title:||Journal of Clinical Microbiology||URI:||http://scholarbank.nus.edu.sg/handle/10635/129604||ISSN:||00951137||DOI:||10.1128/JCM.42.5.2043-2047.2004|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Aug 14, 2020
WEB OF SCIENCETM
checked on Aug 5, 2020
checked on Aug 14, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.